Report Content
Chapter 1 Methodology and Scope
1.1 Market scope and definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates and calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing prevalence of hereditary diseases
3.2.1.2 Advancements in genomic technologies
3.2.1.3 Rising demand for personalized medicine
3.2.1.4 Increasing adoption of non-invasive prenatal testing
3.2.2 Industry pitfalls and challenges
3.2.2.1 High cost of advanced genetic tests
3.3 Growth potential analysis
3.4 Regulatory landscape
3.4.1 U.S.
3.4.2 Europe
3.5 Technology landscape
3.6 Future market trends
3.7 Key news and initiatives
3.8 Gap analysis
3.9 Porter’s analysis
3.10 PESTEL analysis
Chapter 4 Competitive Landscape, 2024
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Disease Type, 2021 – 2034 ($ Mn)
5.1 Key trends
5.2 Hereditary cancer testing
5.2.1 Lung cancer
5.2.2 Breast cancer
5.2.3 Colorectal cancer
5.2.4 Cervical cancer
5.2.5 Ovarian cancer
5.2.6 Prostate cancer
5.2.7 Stomach/gastric cancer
5.2.8 Melanoma
5.2.9 Sarcoma
5.2.10 Uterine cancer
5.2.11 Pancreatic cancer
5.2.12 Other hereditary cancers
5.3 Hereditary non-cancer testing
5.3.1 Genetic tests
5.3.1.1 Cardiac diseases
5.3.1.2 Rare diseases
5.3.1.3 Other diseases
5.3.2 Preimplantation genetic diagnosis & screening
5.3.3 Non-invasive prenatal testing (NIPT) & carrier screening tests
5.3.4 Newborn genetic screening
Chapter 6 Market Estimates and Forecast, By Technology, 2021 – 2034 ($ Mn)
6.1 Key trends
6.2 Cytogenetic
6.3 Biochemical
6.4 Molecular testing
Chapter 7 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)
7.1 Key trends
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Spain
7.3.5 Italy
7.3.6 Netherlands
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Australia
7.4.5 South Korea
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Argentina
7.6 Middle East and Africa
7.6.1 South Africa
7.6.2 Saudi Arabia
7.6.3 UAE
Chapter 8 Company Profiles
8.1 Agilent Technologies
8.2 Centogene
8.3 CooperSurgical
8.4 F. Hoffmann-La Roche
8.5 Fulgent Genetics
8.6 Illumina
8.7 Invitae Corporation
8.8 Laboratory Corporation of America Holdings
8.9 MedGenome
8.10 Myriad Genetics
8.11 Natera
8.12 Quest Diagnostics
8.13 Sophia Genetics
8.14 Thermo Fisher Scientific
8.15 Twist Bioscience
